Research Compound Profile
IGF-1 LR3 is a synthetic analogue of insulin-like growth factor-1, featuring extended biological activity through amino acid modifications at positions 3 and 83. This recombinant peptide demonstrates reduced binding affinity to IGF binding proteins compared to native IGF-1, resulting in prolonged stability in research environments. The compound maintains structural similarity to endogenous IGF-1 while exhibiting enhanced research utility for investigating growth factor signalling cascades. Research scientists at Stroid UK Shop utilise this peptide to examine cellular proliferation mechanisms and metabolic pathway interactions in controlled laboratory settings.
Laboratory Research Applications
Laboratory investigations examine IGF-1 LR3 in cellular culture studies focusing on growth factor receptor binding dynamics and downstream signalling pathway activation. Research protocols evaluate the compound’s effects on protein synthesis machinery, glucose metabolism regulation, and cellular energy expenditure in various tissue culture models. Scientists study its interaction with IGF-1 receptors and insulin receptors to understand cross-reactivity patterns. The peptide serves as a research tool for examining anabolic signalling pathways and their modulation in different experimental conditions. Comparative studies investigate differences between native IGF-1 and this long-acting analogue in cellular response systems. Research teams from our IGF-1 peptide collection utilise this compound alongside other growth factors from our SARMs category and comprehensive peptides range for multi-factorial experimental designs.
Technical Specifications
| Parameter | Specification |
|---|---|
| Molecular Weight | Verify with supplier |
| CAS Number | Verify with supplier |
| Purity | Research grade |
| Form | Lyophilised powder |
| Storage | -20°C, protect from light |
| Stability | 24 months when stored properly |
| Solubility | Water, PBS, saline solutions |
| Sequence Length | 70 amino acids |
Research Compliance
This IGF-1 LR3 0.1mg formulation is manufactured by SIXPEX exclusively for in-vitro research applications. The compound is intended solely for laboratory use by qualified research professionals in controlled experimental environments. This product is not approved for human consumption, therapeutic use, or any application outside legitimate scientific research. Researchers must maintain appropriate laboratory protocols and safety measures when handling this research peptide. All studies should comply with institutional research guidelines and ethical approval processes.
